Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
19.97
0.19 (0.96%)
At close: Jun 16, 2025, 3:59 PM
19.64
-1.65%
Pre-market: Jun 17, 2025, 04:21 AM EDT
Summit Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|
| License and Service Revenue | 4.68M | 1.81M | 860K |
| License and Service Revenue Growth | +158.60% | +110.35% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Latin America Revenue | 705K | 1.81M | 860K | 457K |
| Latin America Revenue Growth | -61.03% | +110.35% | +88.18% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.59M | 14.41M | 20.39M | 13.95M | 11.52M | 9.08M | 5.43M | 6.32M | 6.94M | 7.54M | 5.57M | 6.93M | 6.66M | 7.78M | 5.66M | 5.98M | 4.18M | 3.84M | 7.46M | 5.3M | 3.57M | 3.31M | 5.63M | 1.46M | 2.14M | 3.51M | 5.92M | 3.56M | 3.67M | 4.7M | 2.62M | 3.27M | 3.15M | 3.03M | 2.33M | 2.52M | 2.09M | 2.24M | 2.01M | 1.56M | 1.66M | 1.78M |
| Selling, General, and Administrative Revenue Growth | +8.16% | -29.33% | +46.15% | +21.14% | +26.83% | +67.10% | -13.96% | -8.99% | -7.90% | +35.21% | -19.62% | +4.11% | -14.41% | +37.41% | -5.38% | +42.99% | +8.98% | -48.53% | +40.78% | +48.35% | +7.85% | -41.21% | +284.84% | -31.59% | -39.08% | -40.65% | +66.50% | -3.27% | -21.76% | +79.48% | -19.97% | +3.91% | +3.96% | +30.08% | -7.81% | +20.59% | -6.65% | +11.71% | +28.41% | -5.73% | -6.96% | n/a |
| Research and Development Revenue | 51.27M | 51.4M | 37.72M | 30.8M | 30.87M | 19.46M | 15.32M | 9.45M | 9.88M | 5.39M | 17.05M | 9.01M | 20.56M | 23.11M | 19.94M | 17.3M | 14.7M | 9.55M | 10.64M | 11.48M | 14.89M | 8.19M | 9.32M | 11.21M | 10.7M | 12.51M | 10.41M | 12.94M | 15.87M | 14.02M | 9.81M | 8.69M | 6.51M | 6.39M | 4.83M | 7.13M | 7.02M | 7.12M | 6.95M | 4.22M | 4.83M | 3.41M |
| Research and Development Revenue Growth | -0.26% | +36.25% | +22.49% | -0.24% | +58.61% | +27.03% | +62.13% | -4.37% | +83.49% | -68.41% | +89.27% | -56.18% | -11.04% | +15.87% | +15.31% | +17.65% | +53.88% | -10.20% | -7.34% | -22.88% | +81.88% | -12.17% | -16.85% | +4.76% | -14.50% | +20.13% | -19.53% | -18.44% | +13.22% | +42.89% | +12.94% | +33.41% | +1.80% | +32.43% | -32.30% | +1.57% | -1.32% | +2.46% | +64.44% | -12.58% | +41.66% | n/a |